Page 4 - Trisha Roy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Syndicated Content Jul 12, 2021 | 4:32 PM (Reuters) – The U.S. government on Monday started a review process for national Medicare coverage of Biogen Inc’s Alzheimer’s drug, Aduhelm, that was recently approved by the country’s health regulator. The Centers for Medicare & Medicaid Services expects to give a proposed decision within 6 months and a final decision within 9 months. (https://go.cms.gov/3hzMa6H) (Reporting by Trisha Roy in Bengaluru; Editing by Shounak Dasgupta) '); } return false; }); $('#comments .commentlist .comment-content a').attr('target','_blank'...

By Syndicated Content Jul 12, 2021 | 5:32 PM (Reuters) – The U.S. government on Monday started a review process for national Medicare coverage of Biogen Inc’s Alzheimer’s drug, Aduhelm, that was recently approved by the country’s health regulator. The Centers for Medicare & Medicaid Services expects to give a proposed decision within 6 months and a final decision within 9 months. (https://go.cms.gov/3hzMa6H) (Reporting by Trisha Roy in Bengaluru; Editing by Shounak Dasgupta) '); } return false; }); $('#comments .commentlist .comment-content a').attr('target','_blank'...

NEW YORK (Reuters) — Kids in the United States will likely be able to get COVID-19 vaccinations by the end of this year or the first quarter of 2022, Dr. Anthony Fauci, the nation's top infectious disease expert, said at an event on Wednesday. The United States earlier this month cleared the way for the use of the COVID-19 vaccine from Pfizer and partner BioNTech SE in adolescents aged 12 and above. Fauci also noted the need for a COVID-19 booster shot within a year or so after getting the primary shot. "I think we will almost certainly require a booster sometime within a year or so after g...

By Syndicated Content May 13, 2021 | 4:28 PM (Reuters) – The United States has administered 266,596,486 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 339,165,445 doses, the U.S. Centers for Disease Control and Prevention said on Thursday. Those figures are up from the 264,680,844 vaccine doses the CDC said had gone into arms by Wednesday out of 337,089,765 doses delivered. The agency said 154,624,231 people had received at least one dose while 118,987,308 people are fully vaccinated as of Thursday. The CDC tally includes two-dose vaccines fr...

Inovio Pharmaceuticals plans to begin a global late-stage trial of its COVID-19 vaccine candidate this summer, the company said on Monday, a month after the U.S. government pulled the funding for further studies of the drug.